July 21 (Reuters) – The U.S. FDA said on Tuesday it is launching a pilot program to encourage domestic manufacturing of animal health drugs and reduce the risk of supply chain disruptions. The health
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)